Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1240 in its research report dated November 02, 2022.
Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1240 in its research report dated November 02, 2022.